Transurethral bladder tumor resection alters fibronectin expression in transitional carcinoma cell lines

Journal of Urology

Volumn 157, Issue 3, 1997, Pages 1136-1143

  See, William A ^a,b   Xu, Yong ^a   Gee, Kevin ^a   Severson, Charles ^a   Cohen, Michael B ^a   Ladehoff, David ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

BCG; carcinoma; fibronectin; surgery; transitional cell

Indexed keywords

BCG VACCINE; CANCER GROWTH FACTOR; FIBRONECTIN; MEMBRANE RECEPTOR; SCLEROPROTEIN;

ARTICLE; BACTERIUM ADHERENCE; BCG VACCINATION; BLADDER TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

EID: 0031023234     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65156-5     Document Type: Article

References (26)

1. Catalona, W. J. and Ratliff, T. L.: Bacillus Calmette-Guerin and superficial bladder cancer: clinical experience and mechanism of action. Surg. Ann., 22: 363, 1990.
2. Lamm, D. L., Crissman, J., Blumenstein, B., Crawford, E. D., Montie, J., Scardino, P., Grossman, H. B., Stanisic, T., Smith, J., Sullivan, J. and Sarosdy, M.: Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study. Prog. Clin. Biol. Res., 310: 263, 1989.
3. Martinez-Piñeiro, J. A., León, J. J., Martinez-Piñeiro, L., Jr., Fiter, L., Mositeiro, J. A., Navarro, J., García Matres, M. J. and Cárcamo, P.: Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. J. Urol., 143: 502, 1990.
4. Ratliff, T. L., Palmer, J. O., McGarr, J. A. and Brown, E. J.: Intravesical Bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin. Cancer Res., 47: 1762, 1987.
5. Peake, P., Gooley, A. and Britton, W. J.: Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin. Infect. Immun., 61: 4828, 1993.
6. Garden, R. J., Liu, B. C. S., Redwood, S. M., Weiss, R. E. and Droller, M. J.: Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction. J. Urol., 148: 900, 1992.
7. Ignotz, R. A. and Massague, J.: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem., 261: 4337, 1986.
8. Roberts, A. B., McCune, B. K. and Sporn, M. B.: TGF-β: regulation of the extracellular matrix. Kidney Int., 41: 557, 1992.
9. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. and Sporn, M. B.: Transforming growth factor-beta in human platelets. J. Biol. Chem., 258: 7155, 1983.
10. Cromack, D. T., Sporn, M. B., Roberts, A. B., Merino, M. J., Dart, L. L. and Norton, J. A.: Transforming growth factor-β levels in rat wound chambers. Surg. Res., 42: 622, 1987.
11. Cooper, C. and See, W. A.: The impact of iatrogenic urothelial trauma on urinary levels of transforming growth factor-alpha. J. Urol., 147: 1647, 1992.
12. Jewett, K. A., See, W. A., Sargent, E. R. and Crist, S. A.: Urinary epidermal growth factor levels following various iatrogenic lower urinary tract manipulation. J. Urol., 147: 340A, 1992.
13. Elliott, A. Y., Bronson, D. L., Stein, N. and Fraley, E. E.: In vitro cultivation of epithelial cells derived from tumors of the human urinary tract. Cancer Res., 36: 365, 1976.
14. Williams, R. D.: Human urologic cancer cell lines. Invest. Urol., 17: 359, 1980.
15. See, W. A., Yong, X., Crist, S. and Hedican, S.: Diversity and modulation of plasminogen activator activity in human transitional carcinoma cell lines. J. Urol., 151: 1691, 1994.
16. Neirman, W. C. and Maglott, D. R.: ATCC/NIH Repository Catalogue of Human and Mouse DNA Probes and Libraries. Rockville, M.D.: American Type Culture Collection, 1990.
17. Gause, W. and Adamovicz, J.: Use of PCR to Quantitate Relative Differences in Gene Expression. A Laboratory Manual. Plainview, N.Y.: Cold Spring Harbor Laboratory Press, pp. 293-311, 1995.
18. Yamaori, T.: Localization of cholinergic differentiation factor/leukemia inhibitory factor mRNA in the rat brain and peripheral tissues. Proc. Natl. Acad. Sci. USA, 88: 7298, 1991.
19. Brosman, S. A.: Bacillus Calmette-Guerin immunotherapy: techniques and results. Urol. Clin. North Am., 19: 557, 1992.
20. Patard, J. J., Chopin, D. K. and Boccon-Gibod, L.: Mechanisms of action of Bacillus Calmette-Guerin in the treatment of superficial bladder cancer. World J. Urol., 11: 163, 1993.
21. Becich, M. J., Carroll, S. and Ratliff, T. L.: Internalization of Bacillus Calmett-Guerin by bladder tumor cells. J. Urol., 145: 1316, 1991.
22. Kavoussi, L. R., Brown, E. J., Richie, J. K. and Ratliff, T. L.: Fibronectin mediated Calmette-Guerin Bacillus attachment to murine bladder mucosa: requirement for the expression of an antitumor response. J. Clin. Invest., 85: 62, 1990.
23. Hudson, M. A., Brown, E. J., Richie, J. K. and Ratliff, L.: Modulation of fibronectin mediated Calmette-Guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways. Cancer Res., 51: 3726, 1991.
24. Aslanzadeh, J., Brown, E. J., Quillin, S. P., Richie, J. K. and Ratliff, T. L.: Characterization of soluble fibronectin binding to Bacillus Calmette-Guerin. J. Gen. Microbiol., 135: 2735, 1989.
25. Grossman, H. B., Liebert, M., Wedemeyer, G., Wilson, G. and Flint, A.: Fibronectin distribution in normal and malignant urothelium. J. Urol., 143: 418, 1990.
26. Fleischman, J. D., Park, M. C. and Hassan, M. O.: Fibronectin expression on surgical specimens correlated with the response to intravesical Bacillus Calmette-Guerin therapy. J. Urol., 149: 268, 1993.